Neurotec
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Neurotec - overview
Established
2006
Location
Barcelona, -, Spain
Primary Industry
Healthcare
About
Neurotec is a Spain-based company that operates as a developer of new treatments for acute and chronic Central Nervous System (CNS) diseases.
Current Investors
Inveready Asset Management, Caja Navarra
Primary Industry
Healthcare
Sub Industries
Epidemiology
Website
www.neurotec-pharma.com
Total Amount Raised
Subscriber access only
Neurotec - financials
| Fiscal Year Ended | Dec 31, 2009 | Dec 31, 2010 | Dec 31, 2011 | Dec 31, 2012 | Dec 31, 2013 |
|---|---|---|---|---|---|
| Revenue (USD) | 243,549.6 | 248,031.8 | - | - | - |
| % Revenue Growth (YoY) | - | 1.8% | - | - | - |
| EBITDA (USD) | 145,326.6 | (27,598) | - | - | - |
| Operating Income (USD) | 136,296.9 | (38,468.9) | - | - | - |
| Operating Margin | 56.0% | (15.5%) | - | - | - |
| % EBITDA Margin | 59.7% | (11.1%) | - | - | - |
| NET Income (USD) | 28,124.1 | (32,493.2) | - | - | - |
| % Net Margin | 11.5% | (13.1%) | - | - | - |
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.